Medicine in the United States is in BIG trouble.
We, as physicians, know this all too well. The medical malpractice bonanza that too many patients and their attorneys seek to cash in on is destructive to the delivery of health care in the United States. The deck is stacked against everyone except insurance companies and their lawyers. Without the lawsuits, the insurers couldn't justify the high premiums. The playing field is hardly level. How successful would physicians be if we received two hours of batting practice with Don Mattingly, batting coach for the New York Yankees, and then went out to face Randy Johnson, major league pitcher? Yet, that is the all too common extent of the preparation a physician is given before appearing to testify in a deposition. Physicians are lambs in the legal slaughterhouse, and the lawyers know this all too well. There seems to be no light at the end of the litigious tunnel in which our society thrives. The public has been convinced that a suboptimal medical result is 'someone's fault', and, therefore, someone must pay. Lawyers who make a living suing doctors perpetuate that myth and manipulate our patients into seeing us as the enemy when, in fact, the vast majority of doctors I know are committed to their patients' well-being. The fact that patients opt to continue smoking, eat high fat foods, and/or avoid exercise, is unimportant to the legal profession. The concept of medicine as art is wasted on the public. Litigation is only one factor interfering in our relationships with our patients. Health insurance is becoming prohibitively expensive. Many large and small employers are reducing the amount of health care benefits they provide to their employees. I work in a large institution that offers health insurance. However, I truly cannot afford the plan that would allow my family and me to choose any doctor, get any prescription medication, and go to any hospital we want. As a doctor ... So, I chose a more affordable PPO, and cannot get fexofenadine for my seasonal allergies.
The politicians know that the public is demanding answers. However, they are afraid to offend any constituency. Solutions that limit recoveries benefiting trial lawyers at least as much as their clients, or that regulate malpractice insurers, would be political suicide. There is little reason, if any, to trust that the health care crisis in America today can be resolved in the political arena, where electability matters more than outcomes.
In addition, technology is outpacing the economy. We as a country are facing one of the toughest decisions in the history of health care in the United States. Should everyone have access to the latest technology, regardless of cost, status, stature, insurability, age, comorbid conditions, and life expectancy? I don't believe the public is prepared for the financial ramifications of this decision, regardless of the chosen direction. Do we want to live in a society in which wealthy people live longer because only they have access to the latest technology? If not, how are we, as a society, going to pay for the provision of care to patients who cannot afford the costs?
The obstacles facing patients with chronic illnesses and their physicians are daunting. Doctors are required to spend an inordinate amount of time trying to justify their treatment recommendations to insurers whose goal is cost containment. New treatments and therapies, especially in fields of medicine such as ours, are not covered by insurance solely because they are new. In a specialty like ours, in which our knowledge and treatment tools are constantly being developed, the burden involved in fighting with insurers on behalf of our patients is prohibitive for many of us. Approximately 75% of all health insurance appeals are granted -insurers are counting on insureds not to take these appeals. However, because our patients cannot manage these appeals without our assistance, the burden is on physicians not only to diagnose and prescribe treatment, but also to obtain payment.
I have just touched the tip of the iceberg here. The result of all of this, though, is creating what may be the biggest problem: medicine no longer is attractive to many of the brightest college graduates ... and those of us entering 'old age' may not have the best and brightest caring for our chest pain, intermittent claudication, or cancer. Perhaps I should take comfort in the words once uttered by former Vice President Dan Quayle, who said: 'The future will be better tomorrow.' 2. And then there is vascular medicine. I remember when I was officially elected as the President-Elect of the SVMB. I was initially thrilled, and then quite anxious. I had two years to learn how to successfully act as President. Luckily, I was able to observe some past Presidents, who did incredible things during their terms. My overwhelming desire was to advance vascular medicine and leave an indelible mark on our field. After all, the SVMB remains small in number, but large in influence. To date, I have been unable to leave a legacy of trainees like many of you, since I haven't participated in a formal training program. There aren't trainees out there who refer to me as their mentor. Thus, after much reflection, I concluded that there were two major objectives which would cement the role of vascular medicine in the sphere of vascular disease management, and it was these two objectives to which I dedicated my tenure as your President. One was the proliferation of training programs. The second was establishment of board certification in vascular medicine.
Regarding proliferation of training programs, others, like Alan Hirsch and Mark Creager, already were working on this. In fact, many of us submitted applications to the National Institutes of Health in response to a Request for Application for a Vascular Medicine Training Grant.
Therefore, I quietly began focusing on the second objective: development of a process for board certification in vascular medicine. I owe a tremendous debt of gratitude to Bruce Gray, who listened to me when I proposed this crazy idea to him, and then agreed to work with me on this. Bruce has taken this on as a second full-time job, and for that, I and the SVMB will be eternally grateful.
As you all know, after two years of hard work, we are on the verge of our first certification examinations in vascular and endovascular medicine. Once again, this small society has caught the eye of professional groups 100 times our size! The Society for Cardiovascular Angiography in Interventions and the American College of Cardiology are cosponsoring the American Board of Vascular Medicine! Representatives from SCAI and ACCF sit on the board of the ABVM. And ... the Society for Vascular Surgery, initially not interested in the ABVM, is now asking about potential collaborative opportunities.
We haven't done a perfect job. It has been as difficult as we all anticipated. For example, we had a waiting list of over 100 physicians who wanted to take the Board Review Course, some of whom had never previously missed an SVMB annual meeting. Many of us have had to sheepishly apologize to friends and colleagues of ours about being unable to 'pull strings' to get them in (none of us wanted to meet the Chicago Fire Department officials!).
Some of our nonmedicine colleagues are upset with the entry criteria for the examinations. There have been long and fairly heated discussions about this among the ABVM leadership.
However, despite some methodologic struggles, the exams are fair and balanced, and will provide a clear opportunity for physicians to demonstrate their commitment and expertise in vascular medicine. If this were all I accomplished during my tenure as your President, it would be a source of great pride that will carry me through the next phases of my career and my continued commitment to recognition of our role in the medical community. 3. What has the SVMB been doing? We remain a small but committed group of physicians who know what is required to be the 'primary care providers' to the vascular patient. These are complex patients, and they seem to become tougher every day. Historically, every specialty involved in the management of patients with vascular disease has claimed that this is 'their disease', or 'their patient'. Well, truth be told, the spectrum of illnesses which come through our doors every day is so broad that it is hard to remain masterful of them all. How can an interventionist really expect to know the current therapy for steroid-resistant Takayasu's aortitis? It is the comprehensive vascular medicine specialist who must remain the authority for all aspects of vascular disease care. Unfortunately, the debates that have proliferated during many of the major interventional cardiovascular postgraduate courses are old and banal. 'What is the optimal training for the vascular specialist?' or, 'Who should be the leader of a multidisciplinary vascular center?' These debates, often designed more for entertainment value than for education, do not help us resolve our differences. As we continue to 'fight' over turf, the patient is left in the dust, receiving fragmented, and in some cases inappropriate and unsophisticated vascular care. Robert Fulford once said, 'I have seen the future, and it doesn't work.' Neither do turf battles. As frustrated as we are that the politicians cannot prioritize good public policy over personal aggrandizement, we must resist the temptation ourselves to place our own personal goals before what is best for both our patients and our profession.
As we continue to fight amongst ourselves, the Center for Medicare and Medicaid Services decides that asymptomatic high surgical risk patients with severe carotid stenosis cannot be treated with carotid artery stenting and have the procedure reimbursed by Medicare. Industry adopts a broad group of guidelines written by biased, jaded, nonphysicians, called the Advamed guidelines, making certain that collaboration between pharmaceutical and device manufacturers and physicians is limited. This is going to have a deleterious effect on medical education. We, as physicians, are spending too much time fighting each other, and not enough time defending our patients.
The SVMB has been a cosponsoring organization in all efforts regarding carotid artery stenting ... from credentialing to postmarketing registries, to reimbursement.
We have worked with the Coalition of Quality Ultrasound and remain a founding organization of the Intersocietal Commission for the Accreditation of Vascular Laboratories. In fact, two SVMB members are now on the Executive Committee of the ICAVL. We continue to work to insure the highest quality vascular lab accreditation throughout the United States.
For the first time, the SVMB worked with a major endovascular device manufacturer to develop a balanced and accurate brochure for the evaluation and treatment of carotid artery disease. This has been so successful that we have been asked to develop a second brochure on peripheral arterial disease. These brochures speak to our commitment to education.
What challenges have I left for Dr Cooke?
William Gibson once told us: 'The future is here. It's just not widely distributed yet.' Dr Cooke has a lot of work in front of him.
We must expand our membership. I am hopeful that the ABVM will act as a catalyst for that.
We must insure that the ABVM is successful. The good news is what former major league baseball relief pitcher, Dan Quisenberry, once stated: 'The future is much like the present, only longer. ' We have a few years to demonstrate that the ABVM is the optimal certification pathway for any physician with a background and experience in vascular medicine to demonstrate this to his colleagues and patients.
The SVMB must remain at the forefront of all initiatives that support autonomy for physicians to provide responsible, high quality, economically sound care for our patients.
As I was preparing these comments, I stumbled upon proof that a legendary comment made by one of my boyhood heroes was really not made by him. Yogi Berra, the great philosopher of the modern age, and all-star catcher for the finest baseball team in the history of the universe, once said, 'The future ain't what it used to be.' I loved Yogi for this comment, and found it insightful and humorous. However, I recently discovered that Paul Valery made the identical observation in the early 1900s when he said, 'The trouble with our times is that the future is not what it used to be.' I will learn to accept this.
However, the SVMB, and specifically our patients, cannot accept rhetoric from politicians, attorneys, and biased prognosticators. It is the responsibility of the SVMB leadership to direct the federal government, payers, and physicians to the end zone. Have no fear ... the leadership of the SVMB will navigate these treacherous waters ... we will live with the words of Marcus Aurelius Antoninus: 'Never let the future disturb you. You will meet it, if you have to, with the same weapons of reason which today arm you against the present.' I urge you to give Dr Cooke your full support. You must volunteer your time to support the ABVM, our emerging training programs, our advocacy initiatives, and most importantly, our commitment to patient care, education, and research.
It has truly been an honor to lead you over the past 2 years, and I am confident that our future as leaders in the field of vascular disease, and medicine in general, is secure, especially as I look out at you, my colleagues, in whose most able hands our future lies.
